Efficacy of venom immunotherapy given every 3 or 4 months: A prospective comparison with the conventional regimen

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 1, 2013, Pages 51-54

  Simioni, Livio ^a   Vianello, Alberto ^a   Bonadonna, Patrizia ^b   Marcer, Guido ^c   Severino, Maurizio ^d   Pagani, Mauro ^e   Morlin, Luca ^c   Crivellaro, Mariangiola ^c   Passalacqua, Giovanni ^f  

^a S Maria Del Prato Feltre Hospital   (Italy)

^b Verona General Hospital   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^e Asola Hospital   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYMENOPTERA VENOM; IMMUNOGLOBULIN E;

ADULT; APIS MELLIFERA; ARTICLE; BEE STING; COMPARATIVE EFFECTIVENESS; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INSECT ALLERGY; INSECT STING; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALAISE; MALE; PATIENT SAFETY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRIDOR; TREATMENT DURATION; TREATMENT OUTCOME; UNCONSCIOUSNESS; URTICARIA; VACCINATION; VACCINATION REACTION; VESPULA;

ADULT; BEE VENOMS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INSECT BITES AND STINGS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; WASP VENOMS;

EID: 84871002601     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.09.014     Document Type: Article

References (26)

1. J. Fernandez, M. Blanca, V. Soriano, J. Sanchez, and C. Juarez Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area Clin Exp Allergy 29 1999 1069 1074
2. Y. Graif, O. Romano-Zelekha, I. Livne, M.S. Green, and T. Shohat Allergic reactions to insect stings: results from a national survey of 10 000 junior high school children in Israel J Allergy Clin Immunol 117 2006 1435 1439
3. E. Novembre, A. Cianferoni, and R. Bernardini Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features Clin Exp Allergy 28 1998 834 838
4. B.M. Bilò, and F. Bonifazi Epidemiology of insect-venom anaphylaxis Curr Opin Allergy Clin Immunol 8 2008 330 337
5. L. Simioni, A. Scalco, F. Gastaldelli, R. Bianchi, and A. Fantuzzi Epidemiology of insect sting reactions in Veneto Region (Italy) Allergy 16 1993 115
6. B.M. Biló, F. Rueff, H. Mosbech, F. Bonifazi, J.N. Oude-Elberink EAACI Interest Group on Insect Venom Hypersensitivity Diagnosis of Hymenoptera venom allergy Allergy 60 2005 1339 1349
7. J.E. Moffitt, D.B. Golden, and R.E. Reisman Stinging insect hypersensitivity: a practice parameter update J Allergy Clin Immunol 114 2004 869 886
8. F. Bonifazi, M. Jutel, B.M. Biló, J. Birnbaum, U. Muller EAACI Interest Group on Insect Venom Hypersensitivity Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice Allergy 60 2005 1459 1470
9. I. Finegold Issues in stinging insect allergy immunotherapy: a review Curr Opin Allergy Clin Immunol 8 2008 343 347
10. D.B.K. Golden Long-term outcome after venom immunotherapy Curr Opin Allergy Clin Immunol 10 2010 337 340
11. S. Wöhrl, S. Gamper, W. Hemmer, G. Heinze, G. Stingl, and T. Kinaciyan Premedication with montelukast reduces local reactions of allergen immunotherapy Int Arch Allergy Immunol 144 2007 137 142
12. P. Bonadonna, R. Zanotti, and B. Caruso Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy J Allergy Clin Immunol 121 2008 256 257
13. D.B.K. Golden, A. Kagey-Sobotka, M.D. Valentine, and L.M. Lichtenstein Prolonged-maintenance interval in Hymenoptera venom immunotherapy J Allergy Clin Immunol 67 1981 482 484
14. J. Gadde, A. Sobotka, M. Valentine, L. Lichtenstein, and D. Golden Intervals of six and eight weeks in maintenance venom immunotherapy Ann Allergy 54 1985 348
15. A. Goldberg, and R.E. Reisman Prolonged interval maintenance venom immunotherapy Ann Allergy 61 1988 177 179
16. A. Goldberg, and R. Confino-Cohen Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious J Allergy Clin Immunol 107 2001 902 906
17. E. Cavallucci, S. Ramondo, and A. Renzetti Maintenance venom immunotherapy administered at a 3-month interval preserves safety and efficacy and improves adherence J Investig Allergol Clin Immunol 20 2010 63 68
18. R.U. Muller Insect Sting Allergy: Clinical Picture, Diagnosis and Treatment 1990 Gustav Fischer Verlag Stuttgart, Germany 33
19. W.C. Light, R.E. Reisman, J.I. Wypych, and C.E. Arbesman Clinical and immunological studies of beekeepers Clin Allergy 5 1975 389 395
20. D.W. Hosmer, and S. Lemeshow Applied Logistic Regression 2000 Wiley New York, NY
21. R.E. Reisman, and R. Laintner Further observations of stopping venom immunotherapy: comparison of patients stopped because of a fall in serum venom-specific IgE to insignificant levels with patients stopped prematurely by self-choice J Allergy Clin Immunol 83 1989 1049 1054
22. M.B. Bilò Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment Allergy 66 suppl 95 2011 35 37
23. D.B. Golden, J. Moffitt, and R.A. Nicklas Stinging insect hypersensitivity: a practice parameter update 2011 J Allergy Clin Immunol 127 2011 852 854
24. H.W. Baenkler, S. Meußer-Storm, and G. Eger Continuous immunotherapy for hymenoptera venom allergy using six month intervals Allergol Immunopathol 33 2005 7 14
25. A. Goldberg, and R. Confino-Cohen Effectiveness of maintenance bee venom immunotherapy administered at 6-month intervals Ann Allergy Asthma Immunol 99 2007 352 357
26. D.B. Golden Insect sting allergy and venom immunotherapy: a model and a mystery J Allergy Clin Immunol 115 2005 439 447